Spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease

Arthritis and Rheumatology

Volumn 66, Issue 1, 2014, Pages 213-217

  Khosroshahi, Arezou ^a,b   Cheryk, Lynn A ^c   Carruthers, Mollie N ^b   Edwards, Judith A ^c   Bloch, Donald B ^b   Stone, John H ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Mayo Medical Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; GLUCOCORTICOID; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G4; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; BLOCKING ANTIBODY; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COHORT ANALYSIS; DIAGNOSTIC ERROR; DISEASE ACTIVITY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G4 RELATED DISEASE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROZONE; REMISSION; AGGLUTINATION TEST; AUTOIMMUNE DISEASE; BLOOD; IMMUNOASSAY; LABORATORY DIAGNOSIS; MIDDLE AGED; STATISTICS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGGLUTINATION TESTS; ANTIBODIES, BLOCKING; AUTOIMMUNE DISEASES; DIAGNOSTIC ERRORS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; INDICATORS AND REAGENTS; MALE; MIDDLE AGED;

EID: 84897020074     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38193     Document Type: Article

References (21)

1. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012;366:539-51.
2. Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012;25:1181-92.
3. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-8. (Pubitemid 32204991)
4. Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003;38:982-4. (Pubitemid 37455786)
5. Stone JH, Patel VI, Oliveira GR, Stone JR. Case records of the Massachusetts General Hospital. Case 38-2012. A 60-year-old man with abdominal pain and aortic aneurysms. N Engl J Med 2012;367:2335-46.
6. Carruthers MN, Stone JH, Deshpande V, Khosroshahi A. Development of an IgG4-RD Responder Index. Int J Rheumatol 2012;2012:259408.
7. Chen G, Cheuk W, Chan JK. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Zhonghua Bing Li Xue Za Zhi 2010;39:851-68. In Chinese.
8. Stone JH. IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol 2012;29:177-90.
9. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al, the Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details [review]. Mod Rheumatol 2012;22:1-14.
10. Kamisawa T, Okamoto A, Funata N. Clinicopathological features of autoimmune pancreatitis in relation to elevation of serum IgG4. Pancreas 2005;31:28-31. (Pubitemid 40911499)
11. Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010;62:1755-62.
12. Feldkamp CS. Immunochemical techniques. In: Kaplan LA, Pesce AJ, Kazmierczak SC, editors. Clinical chemistry: theory, analysis, correlation. 4th ed. St. Louis: Mosby; 2003. p. 227-45.
13. Kricka LJ. Principles of immunochemical techniques. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. St. Louis: Elsevier Saunders; 2006. p. 219-43.
14. Raina A, Yadav D, Krasinskas AM, McGrath KM, Khalid A, Sanders M, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol 2009;104:2295-306.
15. Ghazale A, Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007;102:1646-53. (Pubitemid 47206688)
16. Frulloni L, Lunardi C, Simone R, Dolcino M, Scattolini C, Falconi M, et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 2009;361:2135-42.
17. Morselli-Labate AM, Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: a systematic literature review and meta-analysis. J Gastroenterol Hepatol 2009;24:15-36.
18. Yamamoto M, Takahashi H, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, et al. A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease. Mod Rheumatol 2006;16:335-40. (Pubitemid 44921578)
19. Rispens T, Ooievaar-De Heer P, Vermeulen E, Schuurman J, Van Der Neut Kolfschoten M, Aalberse RC. Human IgG4 binds to IgG4 and conformationally altered IgG1 via Fc-Fc interactions. J Immunol 2009;182:4275-81.
20. Kawa S, Kitahara K, Hamano H, Ozaki Y, Arakura N, Yoshizawa K, et al. A novel immunoglobulin-immunoglobulin interaction in autoimmunity. PLoS One 2008;3:e1637.
21. Van Der Neut Kolfschoten M, Schuurman J, Losen M, Bleeker WK, Martinez-Martinez P, Vermeulen E, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007;317:1554-7. (Pubitemid 47417435)